From Safety to Efficacy, Top Five Strategies to Improve Clinical Data Review, Upcoming Webinar Hosted by Xtalks
TORONTO (PRWEB) May 04, 2020 -- The industry is obsessed with speed and flexibility, and rightly so. Nothing exemplifies these characteristics, like the global race for COVID-19 interventions. PerkinElmer’s TIBCO Spotfire solutions have been at the forefront of clinical data visualization and analysis. The company is proud that its products are contributing to developing therapies and vaccines to address this viral pandemic.
This webinar will highlight how many of the challenges our clients experience during clinical trials can be tackled. Analytics can be tailored for specific clinical studies and therapeutic areas. With deep Spotfire, domain expertise and proven industry success, PerkinElmer wants to share the secret sauce on fast and flexible clinical data analysis.
Join Brent Meyers, Director, Clinical & Translational Analytics, PerkinElmer and James Bullis, Sr. Software Service Specialist, PerkinElmer in a live webinar on Tuesday, May 19, 2020 at 11am EDT (4pm BST/UK).
For more information or to register for this event, visit From Safety to Efficacy, Top Five Strategies to Improve Clinical Data Review.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]
Share this article